Resources - amfAR, The Foundation for AIDS Research

Policy and Advocacy Resources

Issue Briefs

Focus on Key Populations Remains Integral to the HIV Response

Domestic Funding Contributions to Health: Comparing Changes in Domestic Financing in PEPFAR and Non-PEPFAR Supported Countries

Dual Epidemics: Leveraging HIV Infrastructure to
Support HPV Prevention, Testing, and Cervical
Cancer Elimination Goals

National Conference to Advance Equity in Mpox Diagnostics: Rapid Summary of Priority Actions — Co-authored with the NYC Pandemic Response Institute

National Conference to Advance Equity in Mpox Diagnostics: Rapid Summary of Priority Actions

Ending HIV:
Zero Out The Epidemic
Not The Budget

Mpox — Co-authored by O’Neill Institute at Georgetown Law

Community Partnerships Make Public Health More Effective: Learning From The 2022 Mpox Outbreak Response

Co-authored by O’Neill Institute at Georgetown Law

MPX Research Gaps: What Remains Unknown

Co-authored by O’Neill Institute at Georgetown Law

Tackling MPX in Black and Latino Communities

Co-authored by O’Neill Institute at Georgetown Law

Monkeypox and Meningococcal Disease
Outbreaks Signal New Health Threats For Communities Heavily Impacted by HIV
And Demand Immediate Action

Key Populations, Size Estimates, and Plans in COP22

Key Populations, Size Estimates,
and Plans in COP22

Violence Crisis Services During Lockdown: An Assessment of Service Availability During COVID-19 Lockdown in South Afric

Issue Brief: The Expanded Mexico City Policy: Implications for the Global Fund

New HIV Testing Strategies in PEPFAR COP19: Rollout and Human Rights Concerns

Expanding Access to Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults: Models for Addressing Consent, Confidentiality, and Payment Barriers

Title X, the Domestic Gag Rule, and the HIV Response

The Effect of the Expanded Mexico City Policy on HIV/AIDS Programming: Evidence from the PEPFAR Implementing Partners Survey

Impact of Mexico City Policy on PEPFAR

The Case for Supervised Consumption Services

Preventing HIV and Hepatitis C Among People Who Inject Drugs: Public Funding for Syringe Services Programs Makes the Difference

Infographics

When Grants End, So Do Scientific Breakthroughs

Cuts to the CDC’s Division of HIV Prevention Will Lead to Dramatic Rise in Infections, Deaths, and Costs

President Trump’s HIV Plan Is Too Valuable to Lose

President Trump’s HIV Plan Is Too Valuable to Lose

The Hidden Cost of Capping NIH Indirect Costs: How Students Pay the Price

The Best Investment You Didn’t Know You Made: How NIH Funding Fuels Innovation and Economic Growth

Most Lifesaving Services Remain Paused: A Rapid Assessment of the PEPFAR Stop Work Order

Ignoring Science Will Worsen the HIV Epidemic in the U.S.

A Dangerous Precedent: Tennessee Rejects
Federal Funds for HIV Prevention

A Dangerous Precedent: Tennessee Rejects
Federal Funds for HIV Prevention

A Neglected Population: Transgender Inclusion in National HIV Plans

A Global Response to HIV Requires the Global Fund

How the Global Fund Improves PEPFAR Investments

Lives on the Line: The Human Impact of Proposed Cuts to Global HIV Funding

Ending the HIV Epidemic Database

How Expanded Mexico City Policy Is Disrupting Global HIV Programs

Getting to Services:
Far, Far Away

When Size Matters: How Social Media Can Help Determine Key Population Size

Context Matters: Ending the HIV Epidemic Among Black Communities

Context Matters: Ending the HIV Epidemic Among Black Communities

Fact Sheets

At-A-Glance: Opioid & Health Indicator Database

Long-Acting Agents in Development for HIV Treatment and Prevention

Reports

Co-authored by TogetHER for Health

The Future of Investment in Global Cervical Cancer Elimination: A Lifesaving Vision at Risk

Community-Led Implementation of Global Fund Programs: Evidence from the SCOPE Study

Community Engagement
in Global Fund Country Coordinating Mechanisms: Findings from the RISE Study

Community Engagement
in Global Fund Country Coordinating Mechanisms: Findings from the RISE Study (PORTUGUESE VERSION)

Community Engagement
in Global Fund Country Coordinating Mechanisms: Findings from the RISE Study (FRENCH VERSION)

Community Engagementin Global Fund Country Coordinating Mechanisms: Findings from the RISE Study (RUSSIAN VERSION)

Community Engagementin Global Fund Country Coordinating Mechanisms: Findings from the RISE Study (SPANISH VERSION)

Structured for Success: Legislative Purpose, Targets, and Focus under PEPFAR vs. International Pandemic Preparedness

Structured-for-Success-2

Structured for Success: Centralized Coordinating Authority under PEPFAR vs. International Pandemic Preparedness

Structured for Success: Political Will, Power, and Process in the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)

Increasing Trans Inclusion in HIV/AIDS National Strategic Planning: Learning from Community Advocacy in Five Countries

Increasing Trans Inclusion in HIV/AIDS National Strategic Planning: Learning from Community Advocacy in Five Countries

Blinded by Our Own Data—Recency Testing in PREPFAR

Blinded by Our Own Data—Recency Testing in PREPFAR

How Cures Can Fail

Context Matters: Health Insurance Coverage Is Fundamental to Ending the HIV Epidemic

Toward an Effective Strategy to Combat HIV, Hepatitis C and the Opioid Epidemic: Recommendations for Policy Makers

Data Watch: Data Accessibility from Global Funders of HIV, TB, and Malaria Programming

Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Overview

Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: From Laboratory to Marketplace

Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Defining the Intended Market

Long-Acting HIV Treatment and Prevention Are Coming: Preparing for Potential Game Changers: Assessing the Payer Landscape